Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
Study Results
Related Studies
A Comparison of EpiCept™ NP-1 Topical Cream vs. Oral Gabapentin in Postherpetic Neuralgia (PHN)
This study has been completed.
Study NCT00475904 Information provided by EpiCept Corporation
First Received on May 17, 2007. Last Updated on July 25, 2011
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Post Herpetic Neuralgia
PHN
Neuropathy
Nerve Pain
Additional conditions recognized in this trial
Neuralgia
Neuralgia, Postherpetic
More general conditions related to this trial
Nervous System Diseases
Neurologic Manifestations
Neuromuscular Diseases
Pain
Peripheral Nervous System Diseases
Signs and Symptoms
Interventions listed in this trial
EpiCept-NP-1 Cream
Gabapentin Capsules
placebo
Additional drug interventions recognized in this trial
Amitriptyline
Amitriptyline, perphenazine drug combination
Gabapentin
Ketamine
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Uptake Inhibitors
Analgesics
Analgesics, Non-Narcotic
Anesthetics
Anesthetics, Dissociative
Anesthetics, General
Anesthetics, Intravenous
Anti-Anxiety Agents
Anti-Dyskinesia Agents
Anticonvulsants
Antidepressive Agents
Antidepressive Agents, Tricyclic
Antimanic Agents
Antiparkinson Agents
Antipsychotic Agents
Calcium Channel Blockers
Cardiovascular Agents
Central Nervous System Agents
Central Nervous System Depressants
Excitatory Amino Acid Agents
Excitatory Amino Acid Antagonists
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Sensory System Agents
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
EpiCept Corporation
Back to top of Main Content
